Benzinga | May 5, 2021 08:06AM EDT

Clovis Oncology Q1 EPS $(0.64) Beats $(0.72) Estimate, Sales $38.10M Miss $44.55M Estimate

Clovis Oncology (NASDAQ:CLVS) reported quarterly losses of $(0.64) per share which beat the analyst consensus estimate of $(0.72) by 11.11 percent. This is a 50 percent increase over losses of $(1.28) per share from the same period last year. The company reported quarterly sales of $38.10 million which missed the analyst consensus estimate of $44.55 million by 14.48 percent. This is a 10.49 percent decrease over sales of $42.56 million the same period last year.